InvestorsHub Logo
Followers 120
Posts 19860
Boards Moderated 0
Alias Born 08/27/2005

Re: jour_trader post# 314089

Sunday, 04/14/2019 3:12:00 PM

Sunday, April 14, 2019 3:12:00 PM

Post# of 415288
Did I say this was about opioid ADFs? No I did not. My comment has nothing to do with Elite's opioid ADF platform.

fighting society headwinds to move away from opiates



Good luck with that fight. A little factoid about the opioid crisis, there is nothing to replace them when it comes to pain management. The waters are plenty charted when it comes to the prescription opioid crisis and Elite
has a viable solution at hand.

Now back to the PE multiple and the fact that the opioid ADF platform was not mentioned by me. Again, I am not even bringing Elite's opioid ADFs into the picture, but if you like I will.

For example the FDA can now retract their belief that acetaminophen is a deterrent in APAPs. Elite has already submitted their ADF for APAPs to the FDA years ago. FDA said not needed. When will the FDA get their heads out of their asses? Probably never so long as Scotty is in charge.

So it is not just the oxycodones, hydrocodones, mophines, and hydromorphones that need to be abuse deterrent. Hybrid drugs like the APAPs also need an ADF formulation because acetaminophen just doesn't cut it as a deterrent.

And if there is information as to a formulation out there that can take the place of these opioids please provide it (them). Opioids are here to stay for quite a while and society can't do much about it at the present time.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News